Loading stock data…
MCK
$814.02-1.18 (-0.14%)
Market ClosedLast close May 1
McKesson Corporation provides healthcare services in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
McKesson Corporation in the Healthcare sector is trading at $814.02. The stock is currently 19% below its 52-week high of $999.00, remaining 0.3% above its 200-day moving average. Technical signals show oversold RSI of 21 and bearish MACD signal, explaining why MCK maintains its current momentum and trend strength. The Whystock Score of 100/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Oversold momentum (RSI 21) — potential for technical mean-reversion
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$814.02
Potential Downside
228.4%
Whystock Fair Value$-1045.10
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus15 analysts
Buy
Mean target$990.87+21.7%
Range$860.00 – $1107
Fundamentals
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Phar...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$102.35B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
23.95
Beta
Defensive asset. Lower volatility than the S&P 500.
0.42
Div Yield
Strong income play. Yield provides a meaningful total return floor.
39.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-243.76%
Volume
Today's trading volume
487,236
Recent News
William Blair Starts McKesson (MCK) at Outperform, Sees Durable Competitive Moat
McKesson Corporation (NYSE:MCK) is included among the 10 Best Large Cap Dividend Growth Stocks to Invest in. On April 28, William Blair initiated coverage of McKesson Corporation (NYSE:MCK) with an Outperform rating. The company has a “durable competitive moat” with specialty-led growth upside, the analyst tells investors in a research note. The firm believes McKesson […]
McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cardinal Health lifts annual profit forecast on strong demand for specialty drugs
April 30 Reuters) - Drug distributor Cardinal Health on Thursday raised its 2026 profit forecast range, betting on strong demand for costly specialty medicines and branded drugs at its pharmaceuticals
2 Things Matter Most in Picking Winning Stocks, Says This Market Pro
Adam Parker’s Trivariate Research analyzes stocks from a macro, fundamental, and quantitative perspective.
McKesson (MCK) Falls More Steeply Than Broader Market: What Investors Need to Know
McKesson (MCK) closed the most recent trading day at $822.63, moving 1.48% from the previous trading session.